Trial intelligence / Profile preview

Ciclesonide HFA Nasal Aerosol for Seasonal Allergic Rhinitis to Mountain Cedar

NCT01010971Phase 3Completed

Sponsor
Sumitomo Pharma America
Start
Dec 2009
Primary completion
Feb 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of fluticasone propionate nasal spray in seasonal allergic rhinitis (SAR), sponsored by Sumitomo Pharma America. Started Dec 2009; status: completed.

02

Drugs

fluticasone propionate nasal spray
03

Conditions

seasonal allergic rhinitis (SAR)

Beyond the preview

Go deeper on NCT01010971.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01010971.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call